| Literature DB >> 20625553 |
Agathe Nkouawa1, Yasuhito Sako, Sonoyo Itoh, Alida Kouojip-Mabou, Christ Nadège Nganou, Yasuaki Saijo, Jenny Knapp, Hiroshi Yamasaki, Minoru Nakao, Kazuhiro Nakaya, Roger Moyou-Somo, Akira Ito.
Abstract
BACKGROUND: Both epilepsy and paragonimiasis had been known to be endemic in Southwest Cameroon. A total of 188 people (168 and 20 with and without symptoms confirmed by clinicians, respectively, 84.6% under 20 years old) were selected on a voluntary basis. Among 14 people (8.3%) with history of epilepsy, only one suffered from paragonimiasis. Therefore, we challenged to check antibody responses to highly specific diagnostic recombinant antigens for two other helminthic diseases, cysticercosis and toxocariasis, expected to be involved in neurological diseases. Soil-transmitted helminthic infections were also examined. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2010 PMID: 20625553 PMCID: PMC2897840 DOI: 10.1371/journal.pntd.0000732
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Figure 1Locations of Bulutu, Ebonji, Etam and Teke in Tombel sub-Division, Southwest Province, Cameroon.
Figure 2ELISA results for paragonimiasis (Pa), cysticercosis (Ts) and toxocariasis (Tc) from 208 persons.
The surveyed persons (n = 208) include 168 and 40 (20 persons from Cameroon (Nc) and 20 from Japan (Nj)) with and without symptoms, respectively. ○, samples with Paragonimus eggs in the sputum. Serology could detect more cases than microscopical examination of sputum and was expected to be more sensitive for detection of paragonimiasis including immature adult stage [11]. ◊, samples positive against the recombinant antigen 100% specific to cysticercosis by immunoblot [17]. The broken line denotes the respective cut-off value for each disease and each cut-off value is shown.
Odds ratio of positive serological test for each symptom among 188 subjects.
| Type of symptom | Serological test | Odds ratio | 95%CI | P value |
| Headache | Paragonimiasis | 1.22 | 0.52–2.87 | 0.999 |
| Toxocariasis | 1.12 | 0.60–2.08 | 0.729 | |
| Haemoptysis | Paragonimiasis | 7.19 | 2.68–19.30 | <0.001 |
| Toxocariasis | 0.99 | 0.40–2.46 | 0.977 | |
| Cough | Paragonimiasis | 2.28 | 0.50–10.29 | 0.284 |
| Toxocariasis | 1.97 | 0.75–5.16 | 0.167 | |
| Chest pain | Paragonimiasis | 1.44 | 0.61–3.43 | 0.406 |
| Toxocariasis | 1.33 | 0.71–2.48 | 0.371 | |
| Eye disorder | Paragonimiasis | 0.91 | 0.23–3.64 | 0.910 |
| Toxocariasis | 1.38 | 0.06–4.31 | 0.521 | |
| Epilepsy | Paragonimiasis | 0.51 | 0.52–3.70 | 0.539 |
| Toxocariasis | 1.30 | 0.39–4.28 | 0.667 |
*Adjusted for age (−10y, 11–20y, >21y) and sex.
Figure 3Immunoblot using the recombinant antigen of the 3 samples showing weak positive response by ELISA.
Sera were in 1∶20 dilutions. Lane 1: negative control, lane 2: positive control, lanes 3–5: samples exhibited weak positive response by ELISA. Lanes 3 and 4 corresponding to the samples showing higher OD value by ELISA were positive to the recombinant antigen by immunoblot.